MUDr. Markéta Bednaříková, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 8280, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 65
2024
-
709O Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study
Year: 2024, type: Conference abstract
-
Faktory zvyšující riziko malignity při nálezu endometriálního polypu v ultrazvukovém obraze
Česká gynekologie-Czech Gynecology, year: 2024, volume: 89, edition: 1, DOI
-
Karcinom endometria
Onkogynekologie, edition: Vyd. 1., year: 2024, number of pages: 18 s.
-
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Gynecologic Oncology, year: 2024, volume: 185, edition: June 2024, DOI
-
Mapování lokalizace sentinelové uzliny u karcinomu endometria
Year: 2024, type: Conference abstract
-
MISMATCH-REPAIR DEFICIENCY IS ASSOCIATED WITH A HIGHER RISK OF RECURRENCE THAN NO SPECIFIC MOLECULAR PROFILE IN EARLY-STAGE ENDOMETRIAL CANCER
Year: 2024, type: Conference abstract
-
Operační léčba recidivujících gynekologických zhoubných nádorů
Ceska Gynekologie-Czech Gynaecology, year: 2024, volume: 89, edition: 4, DOI
-
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet, year: 2024, volume: 404, edition: 10460, DOI
-
Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
Journal of Extracellular Vesicles, year: 2024, volume: 13, edition: 3, DOI
-
Systémová léčba karcinomu děložního hrdla
Onkogynekologie, edition: Vyd. 1., year: 2024, number of pages: 4 s.